Categories: News

CPSI Announces Third Quarter 2021 Results

Highlights for Third Quarter 2021:

  • Revenues of $70.1 million;
  • GAAP net income of $2.7 million and non-GAAP net income of $8.5 million;
  • GAAP earnings per diluted share of $0.19 and non-GAAP earnings per diluted share of $0.59;
  • Adjusted EBITDA of $12.2 million;
  • Bookings of $29.3 million;
  • Cash provided by operations of $1.3 million; and
  • Net debt of $98.1 million

MOBILE, Ala.–(BUSINESS WIRE)–$CPSI–CPSI (NASDAQ: CPSI), a community healthcare solutions company, today announced results for the third quarter and nine months ended September 30, 2021.

Total revenues for the quarter ended September 30, 2021, were $70.1 million, compared with total revenues of $68.3 million for the prior-year third quarter. GAAP net income for the quarter ended September 30, 2021, was $2.7 million, or $0.19 per diluted share, compared with $5.3 million, or $0.36 per diluted share, for the quarter ended September 30, 2020. Cash provided by operations for the third quarter of 2021 was $1.3 million, compared with $8.1 million for the prior-year quarter. Net debt at September 30, 2021, was $98.1 million compared to $77.9 million at the end of the prior-year period.

Total revenues for the nine months ended September 30, 2021, were $206.6 million, compared with total revenues of $197.6 million for the prior-year period. GAAP net income for the nine months ended September 30, 2021, was $13.0 million, or $0.89 per diluted share, compared with $11.1 million, or $0.77 per diluted share, for the nine months ended September 30, 2020. Cash provided by operations for the first nine months of 2021 was $34.5 million, compared with $33.0 million for the prior-year period.

Boyd Douglas, president and chief executive officer of CPSI, stated, “After encountering headwinds in the sales process during the first half of the year, our third quarter performance was underscored by a strong rebound in bookings of $29.3 million. With a higher than historical percentage of Software as a Service (SaaS) revenue in the sales mix, we are very pleased with the continued expansion of recurring revenue.”

Commenting on the Company’s financial performance for the third quarter of 2021, Matt Chambless, chief financial officer of CPSI, stated, “We continue to make meaningful progress towards our strategic initiatives, spurred by TruBridge’s ability to generate both organic and inorganic revenue growth and a transformative shift in electronic health record (EHR) license mix. Together, these factors pushed total recurring revenues, which now make up over 91% of total revenues, to another record level.”

We are laser focused on providing sizeable shareholder returns over the next three years culminating in an end-goal of achieving $80 million in adjusted EBITDA in 2024. Since launching the strategic transformation underway across CPSI, we have been consistently executing on this aggressive, yet obtainable plan, and our progress to date is aligned to that end,” added Douglas.

CPSI will hold a live webcast to discuss its third quarter 2021 results today, Tuesday, November 9, 2021, at 4:30 p.m. Eastern time. A 30-day online replay will be available approximately one hour following the conclusion of the live webcast. To listen to the live webcast or access the replay, visit the Company’s website, www.cpsi.com.

About CPSI

CPSI is a leading provider of healthcare solutions and services for community hospitals, their clinics and post-acute care facilities. Founded in 1979, CPSI is the parent of five companies – Evident, LLC, American HealthTech, Inc., TruBridge, LLC, iNetXperts, Corp. d/b/a Get Real Health and TruCode LLC. Our combined companies are focused on helping improve the health of the communities we serve, connecting communities for a better patient care experience, and improving the financial operations of our customers. Evident provides comprehensive EHR solutions for community hospitals and their affiliated clinics. American HealthTech is one of the nation’s largest providers of EHR solutions and services for post-acute care facilities. TruBridge focuses on providing business, consulting and managed IT services, along with its complete RCM solution, for all care settings. Get Real Health focuses on solutions aimed at improving patient engagement for individuals and healthcare providers. TruCode provides medical coding software that enables complete and accurate code assignment for optimal reimbursement. For more information, visit www.cpsi.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as “expects,” “anticipates,” “estimates,” “believes,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,” “will” and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the Company’s future financial and operational results are forward-looking statements. We caution investors that any such forward‑looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward‑looking statements. Such factors may include: the impact of the ongoing COVID-19 pandemic and related economic disruptions which have materially affected CPSI’s revenue and could materially affect CPSI’s gross margin and income, as well as CPSI’s financial position and/or liquidity; federal, state and local government actions to address and contain the impact of COVID-19 and their impact on us and our hospital clients; operational disruptions and heightened cybersecurity risks due to a significant percentage of our workforce working remotely; significant legislative and regulatory uncertainty in the healthcare industry; exposure to liability for failure to comply with regulatory requirements; saturation of our target market and hospital consolidations; unfavorable economic or market conditions that may cause a decline in spending for information technology and services; general economic conditions, including changes in the financial and credit markets that may affect the availability and cost of credit to us or our customers; potential inability to secure additional financing on favorable terms to meet our future capital needs; our substantial indebtedness, and our ability to incur additional indebtedness in the future; competition with companies that have greater financial, technical and marketing resources than we have; potential future acquisitions that may be expensive, time consuming, and subject to other inherent risks; potential failure to develop new products or enhance current products that keep pace with market demands; failure to develop new technology and products in response to market demands; failure of our products to function properly resulting in claims for medical and other losses; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases free of undetected errors or problems; failure to convince customers to migrate to current or future releases of our products; failure to maintain our margins and service rates; increase in the percentage of total revenues represented by service revenues, which have lower gross margins; exposure to liability in the event we provide inaccurate claims data to payors; exposure to liability claims arising out of the licensing of our software and provision of services; dependence on licenses of rights, products and services from third parties; misappropriation of our intellectual property rights and potential intellectual property claims and litigation against us; interruptions in our power supply and/or telecommunications capabilities, including those caused by natural disaster; our ability to attract and retain qualified client service and support personnel; disruption from periodic restructuring of our sales force; potential inability to properly manage growth in new markets we may enter; exposure to numerous and often conflicting laws, regulations, policies, standards or other requirements through our international business activities; potential litigation against us; pressures on cash flow to service our outstanding debt; restrictive terms of our credit agreement on our current and future operations; changes in and interpretations of financial accounting matters that govern the measurement of our performance; significant charges to earnings if our goodwill or intangible assets become impaired; fluctuations in quarterly financial performance due to, among other factors, timing of customer installations; volatility in our stock price; failure to maintain effective internal control over financial reporting; lack of employment or non-competition agreement with most of our key personnel; inherent limitations in our internal control over financial reporting; vulnerability to significant damage from natural disasters; market risks related to interest rate changes; and other risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission, including, but not limited to, our most recent Annual Report on Form 10-K. Relative to our dividend policy, the payment of cash dividends is subject to the discretion of our Board of Directors and will be determined in light of then-current conditions, including our earnings, our leverage, our operations, our financial conditions, our capital requirements and other factors deemed relevant by our Board of Directors. In the future, our Board of Directors may change our dividend policy, including the frequency or amount of any dividend, in light of then-existing conditions. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.

 
Computer Programs and Systems, Inc.
Condensed Consolidated Statements of Income
(In ‘000s, except per share data)
(Unaudited)
 
Three Months Ended
September 30,
Nine Months Ended
September 30,

2021

2020

2021

2020

Sales revenues:
System sales and support

$

35,560

 

$

40,388

 

$

107,893

 

$

116,297

 

TruBridge

 

34,531

 

 

27,945

 

 

98,736

 

 

81,342

 

Total sales revenues

 

70,091

 

 

68,333

 

 

206,629

 

 

197,639

 

 
Costs of sales:
System sales and support

 

17,425

 

 

17,628

 

 

52,250

 

 

51,901

 

TruBridge

 

17,377

 

 

15,287

 

 

50,349

 

 

44,100

 

Total costs of sales

 

34,802

 

 

32,915

 

 

102,599

 

 

96,001

 

 
Gross profit

$

35,289

 

$

35,418

 

$

104,030

 

$

101,638

 

 
Operating expenses:
Product development

 

7,700

 

 

8,549

 

 

22,598

 

 

25,190

 

Sales and marketing

 

5,200

 

 

6,359

 

 

15,813

 

 

18,526

 

General and administrative

 

14,184

 

 

11,440

 

 

38,322

 

 

34,242

 

Amortization of acquisition-related intangibles

 

3,674

 

 

2,866

 

 

10,114

 

 

8,599

 

Total operating expenses

 

30,758

 

 

29,214

 

 

86,847

 

 

86,557

 

 
Operating income

$

4,531

 

$

6,204

 

$

17,183

 

$

15,081

 

 
Other income (expense):
Other income

 

123

 

 

916

 

 

1,160

 

 

1,241

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

(202

)

Interest expense

 

(825

)

 

(850

)

 

(2,249

)

 

(2,832

)

Total other income (expense)

 

(702

)

 

66

 

 

(1,089

)

 

(1,793

)

 
Income before taxes

$

3,829

 

$

6,270

 

$

16,094

 

$

13,288

 

 
Provision for income taxes

 

1,085

 

 

1,002

 

 

3,065

 

 

2,165

 

 
Net income

$

2,744

 

$

5,268

 

$

13,029

 

$

11,123

 

 
Net income per common share—basic

$

0.19

 

$

0.36

 

$

0.89

 

$

0.77

 

Net income per common share—diluted

$

0.19

 

$

0.36

 

$

0.89

 

$

0.77

 

 
Weighted average shares outstanding used in per common share computations:
Basic

 

14,334

 

 

14,095

 

 

14,276

 

 

14,022

 

Diluted

 

14,342

 

 

14,095

 

 

14,303

 

 

14,022

 

Computer Programs and Systems, Inc.
Condensed Consolidated Balance Sheets
(In ‘000s, except per share data)
 
September 30, 2021
(unaudited)
December 31, 2020
Assets
Current assets
Cash and cash equivalents

$

17,114

 

$

12,671

 

Accounts receivable, net of allowance for doubtful accounts of $1,604 and $1,701, respectively

 

30,542

 

 

32,414

 

Financing receivables, current portion, net

 

7,277

 

 

10,821

 

Inventories

 

1,151

 

 

1,084

 

Prepaid income taxes

 

4,056

 

 

1,789

 

Prepaid expenses and other

 

10,837

 

 

8,365

 

Total current assets

 

70,977

 

 

67,144

 

 
Property & equipment, net

 

12,100

 

 

13,139

 

Software development costs, net

 

9,130

 

 

3,210

 

Operating lease assets

 

7,424

 

 

6,610

 

Financing receivables, net of current portion

 

8,471

 

 

11,477

 

Other assets, net of current portion

 

3,209

 

 

2,787

 

Intangible assets, net

 

98,875

 

 

71,689

 

Goodwill

 

177,196

 

 

150,216

 

Total assets

$

387,382

 

$

326,272

 

 
Liabilities & Stockholders’ Equity
Current liabilities
Accounts payable

$

5,454

 

$

7,716

 

Current portion of long-term debt

 

3,926

 

 

3,457

 

Deferred revenue

 

10,844

 

 

8,130

 

Accrued vacation

 

5,145

 

 

5,353

 

Other accrued liabilities

 

16,245

 

 

12,786

 

Total current liabilities

 

41,614

 

 

37,442

 

 
Long-term debt, less current portion

 

111,298

 

 

73,360

 

Operating lease liabilities, net of current portion

 

5,800

 

 

5,092

 

Deferred tax liabilities

 

12,684

 

 

10,378

 

Total liabilities

 

171,396

 

 

126,272

 

 
Stockholders’ Equity
Common stock, $0.001 par value; 30,000 shares authorized; 14,734 and 14,511 shares issued

 

15

 

 

15

 

Treasury stock, 86 and 47 shares

 

(2,483

)

 

(1,261

)

Additional paid-in capital

 

185,801

 

 

181,622

 

Retained earnings

 

32,653

 

 

19,624

 

Total stockholders’ equity

 

215,986

 

 

200,000

 

 
Total liabilities and stockholders’ equity

$

387,382

 

$

326,272

 

 
Computer Programs and Systems, Inc.
Condensed Consolidated Statements of Cash Flows
(In ‘000s)
(Unaudited)
 
Nine Months Ended September 30,

2021

2020

Operating activities:
Net income

$

13,029

 

$

11,123

 

Adjustments to net income:
Provision for bad debt

 

2,080

 

 

2,695

 

Deferred taxes

 

2,306

 

 

1,060

 

Stock-based compensation

 

4,178

 

 

5,174

 

Depreciation

 

1,641

 

 

1,334

 

Amortization of acquisition-related intangibles

 

10,114

 

 

8,599

 

Amortization of software development costs

 

527

 

 

79

 

Amortization of deferred finance costs

 

220

 

 

242

 

Loss on extinguishment of debt

 

 

 

202

 

Loss on disposal of property and equipment

 

313

 

 

 

Changes in operating assets and liabilities:
Accounts receivable

 

1,304

 

 

3,490

 

Financing receivables

 

5,962

 

 

2,701

 

Inventories

 

(67

)

 

136

 

Prepaid expenses and other

 

(2,892

)

 

(1,765

)

Accounts payable

 

(2,723

)

 

(817

)

Deferred revenue

 

1,414

 

 

(1,174

)

Other liabilities

 

(665

)

 

553

 

Prepaid income taxes

 

(2,267

)

 

(651

)

Net cash provided by operating activities

 

34,474

 

 

32,981

 

 
Investing activities:
Purchase of business, net of cash received

 

(59,634

)

 

 

Investment in software development

 

(6,447

)

 

(2,356

)

Purchases of property and equipment

 

(915

)

 

(3,241

)

Net cash used in investing activities

 

(66,996

)

 

(5,597

)

 
Financing activities:
Dividends paid

 

 

 

(4,338

)

Treasury stock purchases

 

(1,222

)

 

 

Payments of long-term debt principal

 

(2,813

)

 

(3,132

)

Proceeds from long-term debt

 

 

 

67

 

Proceeds from revolving line of credit

 

61,000

 

 

 

Payments of revolving line of credit

 

(20,000

)

 

(15,561

)

Net cash provided by (used in) financing activities

 

36,965

 

 

(22,964

)

 
Net increase in cash and cash equivalents

$

4,443

 

$

4,420

 

 
Cash and cash equivalents, beginning of period

 

12,671

 

 

7,357

 

Cash and cash equivalents, end of period

$

17,114

 

$

11,777

 

Computer Programs and Systems, Inc.
Consolidated Bookings
(In ‘000s)
 
Three Months Ended Nine Months Ended
9/30/2021 9/30/2020 9/30/2021 9/30/2020
System sales and support(1)

$

16,249

$

13,715

$

32,641

$

37,646

TruBridge(2)

 

13,073

 

7,760

 

22,009

 

23,176

 
Total

$

29,322

$

21,475

$

54,650

$

60,822

(1)

Generally calculated as the total contract price (for system sales) and annualized contract value (for support).

(2)

Generally calculated as the total contract price (for non-recurring, project-related amounts) and annualized contract value (for recurring amounts)
Computer Programs and Systems, Inc.
Bookings Composition
(In ‘000s)
(Unaudited)
 
Three Months Ended Nine Months Ended
9/30/2021 9/30/2020 9/30/2021 9/30/2020
System sales and support
Non-subscription sales(1)

$

2,929

$

6,163

$

13,858

$

21,002

Subscription revenue(2)

 

12,437

 

6,557

 

15,316

 

13,656

Other

 

883

 

995

 

3,467

 

2,988

TruBridge
Net new(3)

 

4,794

 

2,997

 

6,278

 

6,811

Cross-sell(3)

 

2,824

 

4,301

 

8,398

 

15,315

Get Real Health

 

5,352

 

462

 

6,760

 

1,050

TruCode

 

103

 

 

573

 

 
Total

$

29,322

$

21,475

$

54,650

$

60,822

(1)

Represents nonrecurring revenues that generally exhibit a timeframe for bookings-to-revenue conversion of five to six months following contract execution.

(2)

Represents recurring revenues to be recognized on a monthly basis over a weighted-average contract period of five years, with a start date in the next 12 months and an average timeframe for commencement of bookings-to-revenue conversion of five to six months following contract execution.

(3)

“Net new” represents bookings from outside the Company’s core EHR client base, and “Cross-sell” represents bookings from existing EHR customers. In each case, generally comprised of recurring revenues to be recognized ratably over a one-year period and an average timeframe for commencement of bookings-to-revenue conversion of four to six months following contract execution.
Computer Programs and Systems, Inc.
Acute Care EHR Net New License Mix
 
Three Months Ended Nine Months Ended
9/30/2021 9/30/2020 9/30/2021 9/30/2020
SaaS(1)

2

3

8

14

Perpetual license(2)

3

5

6

8

Total

5

8

14

22

 

(1)

Exhibit revenue attribution that is recurring in nature.

(2)

Exhibit revenue attribution that is nonrecurring in nature.
Computer Programs and Systems, Inc.
Reconciliation of Non-GAAP Financial Measures
(In ‘000s)
(Unaudited)
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
Adjusted EBITDA:

2021

2020

2021

2020

Net income, as reported

$

2,744

$

5,268

 

$

13,029

$

11,123

 
Deferred revenue and other acquisition-related adjustments

 

388

 

 

 

546

 

Depreciation expense

 

525

 

442

 

 

1,641

 

1,334

Amortization of software development costs

 

262

 

24

 

 

527

 

79

Amortization of acquisition-related intangible assets

 

3,674

 

2,866

 

 

10,114

 

8,599

Stock-based compensation

 

1,700

 

1,564

 

 

4,178

 

5,174

Severance and other nonrecurring charges

 

1,157

 

711

 

 

4,164

 

816

Interest expense and other, net

 

702

 

(66

)

 

1,089

 

1,793

Provision for income taxes

 

1,085

 

1,002

 

 

3,065

 

2,165

 
Adjusted EBITDA

$

12,237

$

11,811

 

$

38,353

$

31,083

 
Computer Programs and Systems, Inc.
Reconciliation of Non-GAAP Financial Measures
(In ‘000s, except per share data)
(Unaudited)
 
Three Months Ended
September 30,
Nine Months Ended
September 30,
Non-GAAP Net Income and Non-GAAP EPS:

2021

2020

2021

2020

Net income, as reported

$

2,744

 

$

5,268

 

$

13,029

 

$

11,123

 

 
Pre-tax adjustments for Non-GAAP EPS:
Deferred revenue and other acquisition-related adjustments

 

388

 

 

 

 

546

 

 

 

Amortization of acquisition-related intangible assets

 

3,674

 

 

2,866

 

 

10,114

 

 

8,599

 

Stock-based compensation

 

1,700

 

 

1,564

 

 

4,178

 

 

5,174

 

Severance and other nonrecurring charges

 

1,157

 

 

711

 

 

4,164

 

 

816

 

Non-operating loss from lease termination (non-cash)

 

313

 

 

 

 

313

 

 

 

Non-cash interest expense

 

73

 

 

73

 

 

220

 

 

242

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

202

 

After-tax adjustments for Non-GAAP EPS:
Tax-effect of pre-tax adjustments, at 21%

 

(1,534

)

 

(1,095

)

 

(4,102

)

 

(3,157

)

Tax shortfall (windfall) from stock-based compensation

 

 

 

 

 

(84

)

 

299

 

 
Non-GAAP net income

$

8,515

 

$

9,387

 

$

28,378

 

$

23,298

 

 
Weighted average shares outstanding, diluted

 

14,342

 

 

14,095

 

 

14,303

 

 

14,022

 

 
Non-GAAP EPS

$

0.59

 

$

0.67

 

$

1.98

 

$

1.66

 

Explanation of Non-GAAP Financial Measures

We report our financial results in accordance with accounting principles generally accepted in the United States of America, or “GAAP.” However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures that are prepared in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management uses these non-GAAP financial measures in order to evaluate the operating performance of the Company and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. In addition, management understands that some investors and financial analysts find these non-GAAP financial measures helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.

As such, to supplement the GAAP information provided, we present in this press release and during the live webcast discussing our financial results the following non‑GAAP financial measures: Adjusted EBITDA, Non-GAAP net income, and Non-GAAP earnings per share (“EPS”).

We calculate each of these non-GAAP financial measures as follows:

  • Adjusted EBITDA – Adjusted EBITDA consists of GAAP net income as reported and adjusts for (i) deferred revenue and other adjustments arising from purchase allocation adjustments related to business acquisitions; (ii) depreciation expense; (iii) amortization of software development costs; (vi) amortization of acquisition-related intangible assets; (v) stock-based compensation; (vi) severance and other non‑recurring charges; (vii) interest expense and other, net; and (viii) the provision for income taxes.
  • Non-GAAP net income – Non-GAAP net income consists of GAAP net income as reported and adjusts for (i) deferred revenue and other adjustments arising from purchase allocation adjustments related to business acquisitions; (ii) amortization of acquisition-related intangible assets; (iii) stock-based compensation; (iv) severance and other non-recurring charges; (v) non-operating loss from lease termination (non-cash); (vi) non-cash interest expense; (vii) loss on extinguishment of debt; and (viii) the total tax effect of items (i) through (vii). Adjustments to Non-GAAP net income also include the after-tax effect of the shortfall (windfall) from stock-based compensation.
  • Non-GAAP EPS – Non-GAAP EPS consists of Non-GAAP net income, as defined above, divided by weighted average shares outstanding (diluted) in the applicable period.

Certain of the items excluded or adjusted to arrive at these non-GAAP financial measures are described below:

  • Deferred revenue and other adjustments – Deferred revenue and other adjustments includes acquisition-related deferred revenue adjustments, which reflect the fair value adjustments to deferred revenues acquired in business acquisitions.

Contacts

Tracey Schroeder

Chief Marketing Officer

Tracey.schroeder@cpsi.com
(251) 639-8100

Read full story here

Staff

Recent Posts

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

1 hour ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

1 hour ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

1 hour ago

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…

1 hour ago

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…

1 hour ago

SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…

1 hour ago